TFX Teleflex Incorporated

Teleflex Focuses on Advancing Respiratory Care at AARC Congress 2016

Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies for critical care and surgery, will showcase its broad portfolio of products for Respiratory Care at the American Association for Respiratory Care (AARC) Congress 2016, October 15-18, in San Antonio, TX. During the event, Teleflex will highlight solutions for Mechanical Ventilation, High Flow Nasal Cannula Therapy, as well as solutions for Arterial Access.

At the Congress, Teleflex will be highlighting the Hudson RCI® Comfort Flo® Plus Cannula, the Hudson RCI® Neptune® Heated Humidifier with ConchaSmartTM Technology and recent portfolio additions from Maxtec®, a leader in oxygen analysis and delivery products for more than 15 years. With these Maxtec additions, Teleflex offers respiratory care professionals a turn-key solution for heated high flow nasal cannula therapy (HFNCT), a new standard of care for patients with acute hypoxemic respiratory failure. HFNCT has been shown to improve survival rates in these patients compared to standard Oxygen Masks or Non-Invasive Ventilation.1

“Teleflex is committed to providing advanced solutions to meet the evolving needs of the respiratory care professional,” said James Ferguson, President of Teleflex, Respiratory Division. “We are proud to be an AARC corporate partner and we are dedicated to enhancing the quality of patients’ lives by improving outcomes through clinical education and technology advancements for respiratory care.”

As respiratory therapists’ scope of practice continues to expand and the placement of arterial catheters is becoming more commonplace in this field, Teleflex will also be highlighting Arrow® Arterial Catheters. The Arrow® Brand leads the market2 with a comprehensive product line of arterial catheters and CDC compliant kits. On Friday, October 14, there will be a preconference educational session titled “Arterial Fundamentals: Ultrasound Guided Arterial Catheter Insertion.” The four-hour simulation course will review best practices for arterial catheter insertion and knowledge of prevention, recognition and management of insertion-related complications from arterial catheters. Teleflex is proud to support the expanded role of the respiratory therapist to include arterial catheter insertion.

Teleflex is honored to invite AARC Congress attendees to stop by Teleflex booth #623 in support of the American Respiratory Care Foundation (ARCF). Teleflex will be donating up to $30,000 to ARCF for AARC Congress attendee in-booth participation, further demonstrating our commitment to connecting clinicians with education in a way that helps improve patient outcomes and advances respiratory care throughout the world.

Learn more at teleflex.com.

About Teleflex Incorporated

Teleflex is a global provider of medical technologies designed to improve the health and quality of people’s lives. We apply purpose driven innovation – a relentless pursuit of identifying unmet clinical needs – to benefit patients and healthcare providers. Our portfolio is diverse, with solutions in the fields of vascular and interventional access, surgical, anesthesia, cardiac care, urology, emergency medicine and respiratory care. Teleflex employees worldwide are united in the understanding that what we do every day makes a difference. For more information, please visit teleflex.com.

Teleflex is the home of Arrow®, Deknatel®, Hudson RCI®, LMA®, Pilling®, Rusch® and Weck® – trusted brands united by a common sense of purpose.

Forward-Looking Statements

Any statements contained in this press release that do not describe historical facts may constitute forward-looking statements. Any forward-looking statements contained herein are based on our management's current beliefs and expectations, but are subject to a number of risks, uncertainties and changes in circumstances, which may cause actual results or company actions to differ materially from what is expressed or implied by these statements. These risks and uncertainties are identified and described in more detail in our filings with the Securities and Exchange Commission, including our Annual Report on Form 10-K.

Teleflex, the Teleflex logo, Arrow, Comfort Flo, ConchaSmart, Deknatel, Hudson RCI, LMA, Neptune, Pilling, Rusch, and Weck are trademarks or registered trademarks of Teleflex Incorporated or its affiliates, in the U.S. and/or other countries.

© 2016 Teleflex Incorporated. All rights reserved. MC-002723

References:

  1. Frat JP, Thille AW, Mercat A, et al. High-Flow Oxygen through Nasal Cannula in Acute Hypoxemic Respiratory Failure. The New England Journal of Medicine 2015: DOI: 10.1056/NEJMoa1503326
  2. IMS Data 2015.

EN
12/10/2016

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Teleflex Incorporated

 PRESS RELEASE

Teleflex Announces Second Quarter 2025 Earnings Conference Call Inform...

Teleflex Announces Second Quarter 2025 Earnings Conference Call Information WAYNE, Pa., July 17, 2025 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE:TFX) will host a conference call to discuss its second quarter financial results and provide an operational update at 8:00 a.m. Eastern Time on Thursday, July 31, 2025. To participate in the conference call, please utilize this to pre-register and receive the dial-in information. The call can also be accessed through a live audio webcast on the company’s website, . An audio replay of the call will be available beginning at 11:00 am Easter...

 PRESS RELEASE

Teleflex Completes Acquisition of BIOTRONIK’s Vascular Intervention Bu...

Teleflex Completes Acquisition of BIOTRONIK’s Vascular Intervention Business WAYNE, Pa., July 01, 2025 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE:TFX), a leading global provider of medical technologies, today announced that it has completed the previously announced acquisition of substantially all of the Vascular Intervention business of BIOTRONIK SE & Co. KG. The acquisition adds a broad portfolio of therapeutic products to Teleflex’s portfolio of interventional access products, driving an enhanced global presence in the cath lab. The Vascular Intervention business will also establi...

 PRESS RELEASE

New Prospective Cohort Study Reporting the Efficacy of Arrow™ Chlorhex...

New Prospective Cohort Study Reporting the Efficacy of Arrow™ Chlorhexidine-Impregnated Central Venous Catheters Demonstrates Reduced Infection Rates Among ICU Patients WAYNE, Pa., June 12, 2025 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced findings from a new multinational study reporting efficacy of Arrow™ Chlorhexidine-Impregnated Central Venous Catheters (CVCs). This prospective cohort study included more than 6,670 patients from 12 Intensive care units in eight hospitals across India, Malaysia, Papua New Guin...

 PRESS RELEASE

Teleflex Highlights Prostate Health and Quality-of-Life Awareness Thro...

Teleflex Highlights Prostate Health and Quality-of-Life Awareness Through Two Key Public Initiatives During Men’s Health Month Timed with National Men’s Health Month, the Prostate Monster ad campaign shines a light on quality-of-life issues associated with benign prostatic hyperplasia or BPH—a condition affecting millions of men1—and encourages them to take control of their health. The Teleflex Prostate Education Express, a mobile training and education center, is on a national tour to educate physicians and the community on prostate health quality-of-life issues associated with BPH and th...

 PRESS RELEASE

Teleflex Publishes 2024 Global Impact Report

Teleflex Publishes 2024 Global Impact Report Highlights Accomplishments and Sets Goals for Corporate Social Responsibility Program WAYNE, Pa., May 19, 2025 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced it has published its 2024 Global Impact Report. The report outlines recent accomplishments and future plans to support the Company’s Corporate Social Responsibility (CSR) program. The report aligns with the Global Reporting Initiative (GRI), the Sustainability Accounting Standards Board (SASB), and Taskforce on Cl...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch